Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Role of simvastatin in prevention of vasospasm and improving functional outcome after aneurysmal sub-arachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled pilot trial.

Garg K, Sinha S, Kale SS, Chandra PS, Suri A, Singh MM, Kumar R, Sharma MS, Pandey RM, Sharma BS, Mahapatra AK.

Br J Neurosurg. 2013 Apr;27(2):181-6. doi: 10.3109/02688697.2012.757293. Epub 2013 Jan 8.

PMID:
23298376
2.

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage.

Chou SH, Smith EE, Badjatia N, Nogueira RG, Sims JR 2nd, Ogilvy CS, Rordorf GA, Ayata C.

Stroke. 2008 Oct;39(10):2891-3. doi: 10.1161/STROKEAHA.107.505875. Epub 2008 Jul 24.

3.

Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study.

McGirt MJ, Garces Ambrossi GL, Huang J, Tamargo RJ.

J Neurosurg. 2009 May;110(5):968-74. doi: 10.3171/2008.10.JNS08901. Review.

PMID:
19199459
4.

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.

Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT.

Stroke. 2005 Sep;36(9):2024-6. Epub 2005 Jul 28.

5.

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.

Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP.

Neurosurgery. 2008 Feb;62(2):422-7; discussion 427-30. doi: 10.1227/01.neu.0000316009.19012.e3.

PMID:
18382320
6.

Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.

Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, Commichau CS, Fitzsimmons BF, Janjua N, Mayer SA, Connolly ES Jr.

Neurosurgery. 2005 Mar;56(3):476-84; discussion 476-84.

PMID:
15730572
7.

Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Trimble JL, Kockler DR.

Ann Pharmacother. 2007 Dec;41(12):2019-23. Epub 2007 Nov 6. Review.

PMID:
17986515
8.

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.

Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A; CONSCIOUS-1 Investigators.

Stroke. 2008 Nov;39(11):3015-21. doi: 10.1161/STROKEAHA.108.519942. Epub 2008 Aug 7.

9.

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N.

Lancet Neurol. 2011 Jul;10(7):618-25. doi: 10.1016/S1474-4422(11)70108-9. Epub 2011 Jun 2.

PMID:
21640651
11.

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

Vergouwen MD, Meijers JC, Geskus RB, Coert BA, Horn J, Stroes ES, van der Poll T, Vermeulen M, Roos YB.

J Cereb Blood Flow Metab. 2009 Aug;29(8):1444-53. doi: 10.1038/jcbfm.2009.59. Epub 2009 May 20.

12.

Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials.

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Frey A, Marr A, Roux S, Kassell NF.

Neurocrit Care. 2010 Dec;13(3):416-24. doi: 10.1007/s12028-010-9433-3.

PMID:
20838933
13.

Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.

Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD; STASH Collaborators.

Lancet Neurol. 2014 Jul;13(7):666-75. doi: 10.1016/S1474-4422(14)70084-5. Epub 2014 May 15.

PMID:
24837690
14.

Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage.

Hoh BL, Topcuoglu MA, Singhal AB, Pryor JC, Rabinov JD, Rordorf GA, Carter BS, Ogilvy CS.

Neurosurgery. 2004 Oct;55(4):779-86; discussion 786-9.

PMID:
15458586
15.

Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.

Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ.

Neurosurgery. 2006 Jun;58(6):1054-65; discussion 1054-65.

PMID:
16723884
16.

A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.

Hänggi D, Eicker S, Beseoglu K, Behr J, Turowski B, Steiger HJ.

Cent Eur Neurosurg. 2009 May;70(2):61-7. doi: 10.1055/s-0028-1087214. Epub 2009 May 25.

PMID:
19711257
17.

Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling.

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Nowbakht P, Roux S, Kassell N.

Stroke. 2012 Jun;43(6):1463-9. doi: 10.1161/STROKEAHA.111.648980. Epub 2012 Mar 8. Erratum in: Stroke. 2012 Jul;43(7):e68.

19.

High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.

Wong GK, Chan DY, Siu DY, Zee BC, Poon WS, Chan MT, Gin T, Leung M; HDS-SAH Investigators.

Stroke. 2015 Feb;46(2):382-8. doi: 10.1161/STROKEAHA.114.007006. Epub 2014 Dec 16.

20.

Clinical characteristics and outcomes of neurogenic stress cadiomyopathy in aneurysmal subarachnoid hemorrhage.

Kilbourn KJ, Levy S, Staff I, Kureshi I, McCullough L.

Clin Neurol Neurosurg. 2013 Jul;115(7):909-14. doi: 10.1016/j.clineuro.2012.09.006. Epub 2012 Sep 26.

PMID:
23021080
Items per page

Supplemental Content

Write to the Help Desk